5-Chloromethyl-3-m-tolyl-[1,2,4]oxadiazole, 95.0%, 5g

8-Fluoroquinolin-3-ol, 95.0%, 1g

Fmoc-iminodipropionic acid, 98.0%, 250mg

1-(6-(2-Bromophenoxy)pyridin-3-yl)ethanone, 95%, 100mg

(S)-2-Chloropropanoic acid, 98.0%, 500g

3-(1-methyl-1H-benzo[d]imidazol-2-yl)propan-1-amine dihydrochloride, 95.0%, 2.5g

1-(6-(4-Nitrophenoxy)pyridin-3-yl)ethanone, 95%, 100mg

1,3-butanediol, min. 99%, for synthesis, 1 l, plastic packaging.

5-Chloro-2,3-dihydro-1H-inden-1-ol, 95.0%, 5g

(R)-4-Hydroxydihydrofuran-2(3H)-one, 95.0%, 1g

2-Amino-N-(tert-butyl)benzenesulfonamide, 95.0%, 10g

2-(tert-Butyl) 4-ethyl 5-amino-3-methylthiophene-2,4-dicarboxylate, 97%, 1g

2-[(1-{[6-(4-chlorophenoxy)pyridin-3-yl]methyl}-2,4-dioxopiperidin-3-yl)formamido]acetic acid, 95%, 5mg